dimer inhibitory peptides of CXCR4 (National Institutes of Health)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namedimer inhibitory peptides of CXCR4 (National Institutes of Health)
Drug Alias Namesynthetic peptides of TM4 (National Institutes of Health)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A